Measuring inconsistency in meta-analyses
Reads0
Chats0
TLDR
A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.Abstract:
Cochrane Reviews have recently started including the quantity I 2 to help readers assess the consistency of the results of studies in meta-analyses. What does this new quantity mean, and why is assessment of heterogeneity so important to clinical practice?
Systematic reviews and meta-analyses can provide convincing and reliable evidence relevant to many aspects of medicine and health care.1 Their value is especially clear when the results of the studies they include show clinically important effects of similar magnitude. However, the conclusions are less clear when the included studies have differing results. In an attempt to establish whether studies are consistent, reports of meta-analyses commonly present a statistical test of heterogeneity. The test seeks to determine whether there are genuine differences underlying the results of the studies (heterogeneity), or whether the variation in findings is compatible with chance alone (homogeneity). However, the test is susceptible to the number of trials included in the meta-analysis. We have developed a new quantity, I 2, which we believe gives a better measure of the consistency between trials in a meta-analysis.
Assessment of the consistency of effects across studies is an essential part of meta-analysis. Unless we know how consistent the results of studies are, we cannot determine the generalisability of the findings of the meta-analysis. Indeed, several hierarchical systems for grading evidence state that the results of studies must be consistent or homogeneous to obtain the highest grading.2–4
Tests for heterogeneity are commonly used to decide on methods for combining studies and for concluding consistency or inconsistency of findings.5 6 But what does the test achieve in practice, and how should the resulting P values be interpreted?
A test for heterogeneity examines the null hypothesis that all studies are evaluating the same effect. The usual test statistic …read more
Citations
More filters
Journal ArticleDOI
Vegetarian Diets and Blood Pressure: A Meta-analysis
Yoko Yokoyama,Yoko Yokoyama,Kunihiro Nishimura,Neal D. Barnard,Neal D. Barnard,Misa Takegami,Makoto Watanabe,Akira Sekikawa,Tomonori Okamura,Yoshihiro Miyamoto +9 more
TL;DR: Consumption of vegetarian diets is associated with lower BP and such diets could be a useful nonpharmacologic means for reducing BP.
Journal ArticleDOI
Associations between ozone and daily mortality: analysis and meta-analysis.
TL;DR: Overall, the results suggest short-term associations between ozone and daily mortality in the majority of the cities, although the estimates appear to be heterogeneous across cities.
Journal ArticleDOI
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Elie A. Akl,Lara A Kahale,Maddalena Barba,Ignacio Neumann,Nawman Labedi,Irene Terrenato,Francesca Sperati,Paola Muti,Holger J. Schünemann +8 more
TL;DR: For the long-term treatment of VTE in patients with cancer, LMWH compared with VKA reduces venous thromboembolic events but not mortality, and the quality of evidence is judged as low for mortality, major bleeding, and minor bleeding; and as moderate for recurrent VTE.
Journal ArticleDOI
Adiponectin and coronary heart disease: a prospective study and meta-analysis.
Naveed Sattar,Goya Wannamethee,Nadeem Sarwar,Julia Tchernova,Lynne Cherry,A. Michael Wallace,John Danesh,Peter H. Whincup +7 more
TL;DR: In contrast to the strong associations previously reported between adiponectin levels and risk of type 2 diabetes, any association with CHD risk is comparatively moderate and requires further investigation.
Journal ArticleDOI
Exercise training for adults with chronic kidney disease
Susanne Heiwe,Stefan H. Jacobson +1 more
TL;DR: The effects of regular exercise in adults with CKD and kidney transplant patients are assessed to determine how the exercise programme should be designed to affect physical fitness and functioning, cardiovascular dimensions, nutrition, lipids, glucose metabolism, systemic inflammation, muscle morphology and morphometrics.
References
More filters
Journal ArticleDOI
Quantifying heterogeneity in a meta‐analysis
TL;DR: It is concluded that H and I2, which can usually be calculated for published meta-analyses, are particularly useful summaries of the impact of heterogeneity, and one or both should be presented in publishedMeta-an analyses in preference to the test for heterogeneity.
Journal ArticleDOI
The combination of estimates from different experiments.
TL;DR: The problem of making a combined estimate has been discussed previously by Cochran and Yates and Cochran (1937) for agricultural experiments, and by Bliss (1952) for bioassays in different laboratories as discussed by the authors.
Journal ArticleDOI
Tamoxifen for early breast cancer: An overview of the randomised trials
TL;DR: The absolute improvement in recurrence was greater during the first 5 years, whereas the improvement in survival grew steadily larger throughout the first 10 years, and these benefits appeared to be largely irrespective of age, menopausal status, daily tamoxifen dose, and of whether chemotherapy had been given to both groups.
Journal Article
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group
TL;DR: There have been many randomised trials of adjuvant tamoxifen among women with early breast cancer, and an updated overview of their results is presented in this paper, which approximately doubles the amount of evidence from trials of about 5 years of tamoxifier and, taking all trials together, on events occurring more than 5 years after randomisation.
Journal ArticleDOI
Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis.
TL;DR: In this paper, the authors evaluated standard error, precision (inverse of standard error), variance, inverse of variance, sample size and log sample size (vertical axis) and log odds ratio, log risk ratio and risk difference (horizontal axis).